Widen E., Eriksson JG, Groop LCMetformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM. Diabetes1992;41:354-58.
2.
Bailey CJBiguanides and NIDDM. Diabetes Care1992;15(6):755-72.
3.
Miller RR, Greenblatt DJHandbook of drug therapy. New York: Elsevier, 1979:685-92.
4.
Hermann LSBiguanides and sulfonylureas as combination therapy in NIDDM. Diabetes Care.1990;13(suppl3):37-41.
5.
Hermann LS, Karlsson JE, Sjostrand A.Prospective comparative study in NIDDM patients of metformin and glibenclamide with special reference to lipid profiles. Eur J Clin Pharmacol1991;41:263-65.
6.
Groop LCSulfonylureas in NIDDM. Diabetes Care1992 ;15(6):737-54.
7.
Stout RW, Brunzell JD, Bierman EL, Porte D.Effect of phenformin on glucose-insulin interrelationships. Diabetes1974;23:624-30.
Wu MS, Johnston P., Sheu Whh, et al. Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients. Diabetes Care1991;13(1):1-8.
10.
DeFronzo RA , Barzilai N., Simonson DCMechanism of metformin action in obese and lean non-insulin-dependent diabetic subjects. J Clin EndocrinolMetab1991;73:1294-1301.
11.
Dorman TL, Heller SR, Peck GM, Tattersall RBDouble-blind evaluation of efficacy and tolerability of metformin in NIDDM . Diabetes Care1991;14(4):342-43.
12.
Perriello G. , Misericordia P., Volpi E., et al. Acute antihyperglycemic mechanisms of metformin in NIDDM. Diabetes1994;43:920-82.
13.
Sum CF, Webster JM, Johnson AB, Catalano C., Cooper BG, Taylor R.The effect of intravenous metformin on glucose metabolism during hyperglycaemia in type II diabetes. Diabetic Med1992;9:61-65.
14.
Benzi L., Trischitta V., Ciccarone A., et al. Improvement with metformin in insulin intemalization and processing in monocytes from NIDDM patients. Diabetes1990;39:844-49.
15.
Janssen M., Rillaerts E., De Leeuw I.Effects of metformin on haemorheology, lipid parameters and insulin resistance in insulin-dependent diabetic patients (IDDM). Biomed Pharmacother1991;45: 363-67.
16.
Pentikainen PJ, Voutilainen E., Aro An , Uusitupa M., Penttila I., Vapaatalo H.Cholesterol lowering effect of metformin in combined hyperlipidemia: placebo controlled double blind trial. Ann Med1990;22:307-12:
17.
Khan IH, Catto Grd, MacLeod AM. Severe lactic acidosis in patient receiving continuous ambulatory peritoneal dialysis. Br Med J1993 ;307: 1056-57.
18.
Gan SC, Barr J., Arieff AI, Pearl RGBiguanide-associated lactic acidosis. Arch Intern Med1992;152:2333-36.
19.
Olin BR, Hebel SK, Dombek CE,Kastrup EK, eds. Drug facts & comparisons . St. Louis: Facts & Comparison, Inc,1994:762.
20.
McIntyre HD , Ma A., Bird DM, Paterson CA, Ravenscroft PJ, Cameron DPMetformin increases insulin sensitivity and basal glucose clearance in type 2 (non-insulin-dependent) diabetes mellitus . AustNZJMed1991;21:714-19.
21.
Reaven GM, Johnston P., Hollenbecle CB, et al. Combined metformin-sulfonylurea treatment of patients with non-insulin-dependent diabetes in fair to poor glycemic control. J Clin Endocnhol Metab1002;74:1020-26.
22.
Lamey PJ, Gibson J., Barclay SC, Miller S.Grinspan's syndrome: a drug-induced phenomenon? Oral Surg Oral Med Oral Path1990;70: 184-85.
23.
Jeppesen J., Zhou MY, Chen Ydi, Reaven GMEffect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM. Diabetes Care1994;17(10):1093-99.
24.
Hermann LS, Schersten B., Bitzen PO, Kjellstrom T., Lindgarde F., Melander A.Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. Diabetes Care1994;17(10):1100-9.